LMAT LeMaitre Vascular Inc.

LeMaitre to Participate at Upcoming Investor Conferences in March

LeMaitre to Participate at Upcoming Investor Conferences in March

BURLINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.

Oppenheimer 34th Annual Healthcare MedTech & Services Conference (Virtual)

Tuesday, March 12, 2024

David Roberts, President, will present at 11:20 AM EDT

Barclays Global Healthcare Conference

Thursday, March 14, 2024

Loews Miami Beach Hotel, Miami Beach, FL

David Roberts, President, will present at 10:15 AM EDT

36th Annual Roth Conference 2024

Tuesday, March 19, 2024

The Ritz Carlton, Laguna Niguel located in Dana Point, CA

JJ Pellegrino, Chief Financial Officer, will present at 11 AM PDT

KeyBanc Life Sciences & MedTech Investor Forum (Virtual)

Wednesday, March 20, 2024

David Roberts, President, will present at 11:15 AM EDT

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit .

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.



Contact: 
LeMaitre Vascular, Inc. 
Sandra Millar
EN
01/03/2024

Underlying

LMATLeMaitre Vascular Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LeMaitre Vascular Inc.

 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre Q1 2024 Financial Results

LeMaitre Q1 2024 Financial Results BURLINGTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2024 results, announced a $0.16/share quarterly dividend and provided guidance. Q1 2024 Financial Results Sales $53.5mm, +14% (+11% organic) vs. Q1 2023  Gross margin 68.6%, +300 bpsOp. income $11.9mm, +51%Op. margin 22%Net income $9.9mm, +64%Earnings per diluted share $0.44, +62%Cash up $3.2mm sequentially to $108.3mm Allografts (+31%), bovine patches (+13%), carotid shunts (+27%) and distributed porcine...

May 2, 2024 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024

LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024 BURLINGTON, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the live call. The au...

April 19, 2024 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conf...

LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference BURLINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 11:30 AM ET. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets dis...

March 26, 2024 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre to Participate at Upcoming Investor Conferences in March

LeMaitre to Participate at Upcoming Investor Conferences in March BURLINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March. Oppenheimer 34th Annual Healthcare MedTech & Services Conference (Virtual)Tuesday, March 12, 2024David Roberts, President, will present at 11:20 AM EDT Barclays Global Healthcare ConferenceThursday, March 14, 2024Loews Miami Beach Hotel, Miami Beach, FLDavid Roberts, President, will present at 10:15 AM EDT 36th Annual Roth Confere...

March 1, 2024 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre Q4 2023 Financial Results

LeMaitre Q4 2023 Financial Results BURLINGTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2023 results, announced a $0.16/share quarterly dividend and provided guidance. Q4 2023 Financial Results Sales $48.9mm, +19% (+14% organic) vs. Q4 2022Gross margin 68.1%, +450 bpsOp. income $10.2mm, +46%Op. margin 21%Net income $8.5mm, +50%Earnings per diluted share $0.38, +49%Cash up $8.1mm sequentially to $105.1mm Bovine patches (+18%), allografts (+52%), valvulotomes (+12%), carotid shunts (+16%) and...

February 27, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch